(Q43999565)

28 November 2017

Impairment of hepatic Stat-3 activation and reduction of PPARalpha activity in fructose-fed rats (English)

1 reference

28 November 2017

1

1 reference

28 November 2017

4

1 reference

28 November 2017

Laia Vilà

2

0 references

Juan C. Laguna

object named as

Juan Carlos Laguna

7

0 references

author name string

Mireia Farré

3

1 reference

28 November 2017

Rosa María Sánchez

5

1 reference

28 November 2017

Manuel Vázquez-Carrera

6

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 March 2007

1 reference

28 November 2017

1 reference

28 November 2017

45

1 reference

28 November 2017

778-788

1 reference

28 November 2017

3

1 reference

Amelioration of high fructose-induced metabolic derangements by activation of PPARalpha

28 November 2017

1 reference

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

7 January 2021

Cardiovascular morbidity and mortality associated with the metabolic syndrome

1 reference

7 January 2021

Fructose, weight gain, and the insulin resistance syndrome

1 reference

7 January 2021

Sugars, hypertriglyceridemia, and cardiovascular disease

1 reference

7 January 2021

Intermediary metabolism of fructose

1 reference

7 January 2021

Single nucleotide polymorphism (-468 Gly to A) at the promoter region of SREBP-1c associates with genetic defect of fructose-induced hepatic lipogenesis [corrected].

1 reference

7 January 2021

Atorvastatin treatment induced peroxisome proliferator-activated receptor alpha expression and decreased plasma nonesterified fatty acids and liver triglyceride in fructose-fed rats

1 reference

7 January 2021

Carbohydrate-induced hypertriglyceridemia: modifying factors and implications for cardiovascular risk

1 reference

7 January 2021

PPAR alpha is necessary for the lipopenic action of hyperleptinemia on white adipose and liver tissue

1 reference

7 January 2021

Aging-induced up-regulation of nuclear binding activities of oxidative stress responsive NF-kB transcription factor in mouse cardiac muscle.

1 reference

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

7 January 2021

Assay of peroxisomal beta-oxidation of fatty acids

1 reference

7 January 2021

Lack of hypotriglyceridemic effect of gemfibrozil as a consequence of age-related changes in rat liver PPARalpha

1 reference

7 January 2021

Expression of the Peroxisome Proliferator-activated Receptor Gene Is Stimulated by Stress and Follows a Diurnal Rhythm

1 reference

7 January 2021

Enhanced DNA binding and activation of transcription factors NF-kappa B and AP-1 by acetaldehyde in HEPG2 cells

1 reference

7 January 2021

Increased reactive oxygen species production down-regulates peroxisome proliferator-activated alpha pathway in C2C12 skeletal muscle cells

1 reference

7 January 2021

Nuclear factor-kappaB activation leads to down-regulation of fatty acid oxidation during cardiac hypertrophy

1 reference

7 January 2021

Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms

1 reference

7 January 2021

The biosynthesis of hepatic cholesterol esters and triglycerides is impaired in mice with a disruption of the gene for stearoyl-CoA desaturase 1

1 reference

7 January 2021

Structure and function of animal fatty acid synthase

1 reference

7 January 2021

Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): two key regulators of glucose metabolism and lipid synthesis in liver

1 reference

7 January 2021

SREBP-1c mediates the insulin-dependent hepatic glucokinase expression.

1 reference

7 January 2021

A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver

1 reference

7 January 2021

Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries.

1 reference

7 January 2021

Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia

1 reference

7 January 2021

STAT3 signalling is required for leptin regulation of energy balance but not reproduction

1 reference

7 January 2021

Leptin receptor action and mechanisms of leptin resistance

1 reference

7 January 2021

Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation

1 reference

7 January 2021

Transcriptional profiling reveals global defects in energy metabolism, lipoprotein, and bile acid synthesis and transport with reversal by leptin treatment in ob/ob mouse liver

1 reference

7 January 2021

Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo

1 reference

7 January 2021

Adiponectin and adiponectin receptors

1 reference

7 January 2021

The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression

1 reference

7 January 2021

Induction of the peroxisome proliferator activated receptor by fenofibrate in rat liver

1 reference

7 January 2021

Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system

1 reference

7 January 2021

Stabilization of peroxisome proliferator-activated receptor alpha by the ligand

1 reference

7 January 2021

Glucose Down-regulates the Expression of the Peroxisome Proliferator-activated Receptor-α Gene in the Pancreatic β-Cell

1 reference

7 January 2021

Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis

1 reference

7 January 2021

Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha)

1 reference

7 January 2021

The transcriptional and DNA binding activity of peroxisome proliferator-activated receptor alpha is inhibited by ethanol metabolism. A novel mechanism for the development of ethanol-induced fatty liver

1 reference

7 January 2021

Reduction of postprandial hyperglycemia in patients with type 2 diabetes reduces NF-kappaB activation in PBMCs

1 reference

7 January 2021

High dietary fructose induces a hepatic stress response resulting in cholesterol and lipid dysregulation

1 reference

7 January 2021

Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease

1 reference

7 January 2021

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

1 reference

7 January 2021

Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity

1 reference

7 January 2021

Peroxisome proliferator activated receptor-alpha expression in human liver.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21499

1 reference

28 November 2017

1 reference